Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital

Journal of Clinical Microbiology

Volumn 38, Issue 2, 2000, Pages 866-869

  Marchese, A ^a,b   Balistreri, G ^a   Tonoli, E ^a   Debbia, E A ^a   Schito, G C ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Institute of Microbiology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CONCENTRATION (PARAMETERS); ITALY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 0033961008     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.2.866-869.2000     Document Type: Article

References (18)

1. Ariza, J., M. Pujol, J. Cabo, C. Pena, N. Fernandez, J. Linares, J. Ayats, and F. Gudiol. 1999. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 353:1587-1588.
2. Centers for Disease Control and Prevention. 1997. Staphylococcus aureus with reduced susceptibility to vancomycin-United States. Morbid. Mortal. Weekly Rep. 46:765-766.
3. de Lencastre, H., and A. Tomasz. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 38:2590-2598.
4. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguzi, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
5. Hiramatsu, K., N. Aritaka, H. Hanki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi, and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670-1673.
6. Kaatz, G. W., S. M. Seo, N. J. Dorman, and S. A. Lerner 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
7. Mainardi, J., D. M. Shales, R. V. Goering, J. H. Shales, J. F. Acar, and F. W. Goldstein. 1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 171:1646-1650.
8. Marchese, A., E. A. Debbia, D. Bacca, G. Balistreri, B. Musolino, and G. C. Schito. 1997. Multidrug-resistant gram-positive pathogens. Drugs 54(Suppl. 6): 11-20.
9. Moreira, B., S. Boyle-Vara, B. L. M. deJonge, and R. S. Kaum. 1997. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 41:1788-1793.
10. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed., vol. 17, no. 2. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Ploy, M. C., C. Greland, C. Martin, L. de Lumley, and F. Denis. 1998. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 351:1212.
12. Roberts, R. B., A. de Lencastre, W. Eisner, E. P. Severina, B. Shopsin, B. N. Kreiswirth, A. Tomasz, and the MRSA Collaborative Study Group. 1998. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. Infect. Dis. 178:164-171.
13. Sieradzky, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566.
14. Siradzki, K., R. B. Roberts, S. W. Harber, and A. Tomasz. 1999. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340:517-523.
15. Spencer, R. C., A. Bauernfeind, J. Garcia-Rodriguez, V. Jarlier, M. Pfaller, J. Turnidge, and A. Voss. 1997. Surveillance of the current resistance of nosocomial pathogens to antimicrobials. Clin. Microbiol. Infect. 3(Suppl. 1):S21-S35.
16. Tacchetti, C., R. Quarto, L. Nitsch, D. J. Hartmann, and R. Cancedda. 1987. In vitro morphogenesis of chick embryo hypertrophic cartilage. J. Cell Biol. 105:999-1006.
17. Tenover, F. C., M. V. Lancaster, B. C. Hill, C. D. Steward, S. A. Stocker, G. A. Hancock, C. M. O'Hara, N. C. Clark, and K. Hiramatsu. 1998. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J. Clin. Microbiol. 36:1020-1027.
18. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced hy pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.